Mal-amido-PEG8-NHS

Mal-amido-PEG8-NHS

Catalog Number:
PG01492909ALA
Mfr. No.:
M595557-100mg; M595557-500mg; M595557-1g
Price:
$794
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Mal-amido-PEG8-NHS is a PEG derivative containing a maleimide group and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. The maleimide group will react with a thiol group to form a covalent bond, enabling the connection of biomolecule with a thiol.

          Please contact us at for specific academic pricing.

      • Properties
        • Alternative Name
          756525-93-6 | Mal-amido-PEG8-NHS | Mal-amido-PEG8-NHS ester | Maleimide-PEG8-NHS ester | Maleimide PEG8 succinimidyl ester | Maleimide-NH-PEG8-CH2CH2COONHS Ester | 2,5-dioxopyrrolidin-1-yl 1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25,28-octaoxa-
          CAS Number
          756525-93-6
          Molecular Formula
          C30H47N3O15
          Molecular Weight
          689.71
          Purity
          95%
          Storage
          Store at -20°C
          Shipping
          Dry ice
          SMILES
          C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCN2C(=O)C=CC2=O
          InChi
          InChI=1S/C30H47N3O15/c34-25(5-8-32-26(35)1-2-27(32)36)31-7-10-41-12-14-43-16-18-45-20-22-47-24-23-46-21-19-44-17-15-42-13-11-40-9-6-30(39)48-33-28(37)3-4-29(33)38/h1-2H,3-24H2,(H,31,34)
          InChi Key
          MTPWCXBUZLEBDD-UHFFFAOYSA-N
          PubChem CID
          57568672
          Others
          IUPAC Name: (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate

          * For research use only. Not for use in human or animal.

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.